AIIMS expects Covaxin to be ready for children above 2 years old by September, 2021
Coimbatore: Covaxin's data for children's Phase 2 and 3 trials will be available by September. Director of Delhi AIIMS Dr.Randeep Guleria said the approval is expected the same month. Delhi AIIMS have screening children in age group of 2-17 for these vaccines since June 7
The DCGI had granted permission to Bharat Biotech to carry out phase 2, phase 3 trials of Covaxin on children from the age of 2 on May 12. The sero-positivity study by AIIMS (New Delhi) and WHO has found high positivity in children and it has thus indicated that the third wave may not affect children more than adults.
The DCGI had granted permission to Bharat Biotech to carry out phase 2, phase 3 trials of Covaxin on children from the age of 2 on May 12. The sero-positivity study by AIIMS (New Delhi) and WHO has found high positivity in children and it has thus indicated that the third wave may not affect children more than adults.